ID   LYNX1_HUMAN             Reviewed;         116 AA.
AC   P0DP58; A0A140VJN6; D3DWI7; G3XAC2; Q86SR0; Q9BZG9;
DT   05-JUL-2017, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2017, sequence version 1.
DT   07-APR-2021, entry version 28.
DE   RecName: Full=Ly-6/neurotoxin-like protein 1 {ECO:0000305};
DE   AltName: Full=Endogenous prototoxin LYNX1 {ECO:0000303|PubMed:21252236};
DE   AltName: Full=Testicular tissue protein Li 112 {ECO:0000312|EMBL:AEE61023.1};
DE   Flags: Precursor;
GN   Name=LYNX1 {ECO:0000312|HGNC:HGNC:29604};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-80 (ISOFORM 1).
RA   Southan C., Simms M., Narjis S.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
RX   PubMed=26033490; DOI=10.1016/j.intimp.2015.05.030;
RA   Moriwaki Y., Takada K., Tsuji S., Kawashima K., Misawa H.;
RT   "Transcriptional regulation of SLURP2, a psoriasis-associated gene, is
RT   under control of IL-22 in the skin: A special reference to the nested gene
RT   LYNX1.";
RL   Int. Immunopharmacol. 29:71-75(2015).
RN   [6]
RP   STRUCTURE BY NMR OF 21-93 (ISOFORM 1), FUNCTION, DISULFIDE BONDS, AND
RP   MISCELLANEOUS.
RX   PubMed=21252236; DOI=10.1074/jbc.m110.189100;
RA   Lyukmanova E.N., Shenkarev Z.O., Shulepko M.A., Mineev K.S., D'Hoedt D.,
RA   Kasheverov I.E., Filkin S.Y., Krivolapova A.P., Janickova H., Dolezal V.,
RA   Dolgikh D.A., Arseniev A.S., Bertrand D., Tsetlin V.I., Kirpichnikov M.P.;
RT   "NMR structure and action on nicotinic acetylcholine receptors of water-
RT   soluble domain of human LYNX1.";
RL   J. Biol. Chem. 286:10618-10627(2011).
RN   [7]
RP   FUNCTION.
RX   PubMed=28100642; DOI=10.1096/fj.201600733r;
RA   George A.A., Bloy A., Miwa J.M., Lindstrom J.M., Lukas R.J., Whiteaker P.;
RT   "Isoform-specific mechanisms of alpha3beta4*-nicotinic acetylcholine
RT   receptor modulation by the prototoxin lynx1.";
RL   FASEB J. 31:1398-1420(2017).
CC   -!- FUNCTION: Acts in different tissues through interaction to nicotinic
CC       acetylcholine receptors (nAChRs) (PubMed:21252236). The proposed role
CC       as modulator of nAChR activity seems to be dependent on the nAChR
CC       subtype and stoichiometry, and to involve an effect on nAChR
CC       trafficking and its cell surface expression, and on single channel
CC       properties of the nAChR inserted in the plasma membrane. Modulates
CC       functional properties of nicotinic acetylcholine receptors (nAChRs) to
CC       prevent excessive excitation, and hence neurodegeneration. Enhances
CC       desensitization by increasing both the rate and extent of
CC       desensitization of alpha-4:beta-2-containing nAChRs and slowing
CC       recovery from desensitization. Promotes large amplitude ACh-evoked
CC       currents through alpha-4:beta-2 nAChRs. Is involved in regulation of
CC       the nAChR pentameric assembly in the endoplasmic reticulum. Shifts
CC       stoichiometry from high sensitivity alpha-4(2):beta-2(3) to low
CC       sensitivity alpha-4(3):beta-2(2) nAChR (By similarity). In vitro
CC       modulates alpha-3:beta-4-containing nAChRs. Reduces cell surface
CC       expression of (alpha-3:beta-4)(2):beta-4 and (alpha-3:beta-4)(2):alpha-
CC       5 nAChRs suggesting an interaction with nAChR alpha-3(-):(+)beta-4
CC       subunit interfaces and an allosteric mode. Corresponding single channel
CC       effects characterized by decreased unitary conductance, altered burst
CC       proportions and enhanced desensitization/inactivation seem to depend on
CC       nAChR alpha:alpha subunit interfaces and are greater in (alpha-3:beta-
CC       2)(2):alpha-3 when compared to (alpha-3:beta-2)(2):alpha-5 nAChRs
CC       (PubMed:28100642). Prevents plasticity in the primary visual cortex
CC       late in life (By similarity). {ECO:0000250|UniProtKB:P0DP60,
CC       ECO:0000269|PubMed:21252236, ECO:0000269|PubMed:28100642}.
CC   -!- SUBUNIT: Interacts with nAChRs containing alpha-4:beta-2
CC       (CHRNA4:CHRNB2) and alpha-7 (CHRNA7) subunits. Interacts with CHRNA4
CC       probably in the endoplasmic reticulum prior to nAChR pentameric
CC       assembly (By similarity). {ECO:0000250|UniProtKB:P0DP60}.
CC   -!- INTERACTION:
CC       P0DP58-2; P55212: CASP6; NbExp=3; IntAct=EBI-21916939, EBI-718729;
CC       P0DP58-2; Q8NI60: COQ8A; NbExp=3; IntAct=EBI-21916939, EBI-745535;
CC       P0DP58-2; P22607: FGFR3; NbExp=3; IntAct=EBI-21916939, EBI-348399;
CC       P0DP58-2; P06396: GSN; NbExp=3; IntAct=EBI-21916939, EBI-351506;
CC       P0DP58-2; P13473-2: LAMP2; NbExp=3; IntAct=EBI-21916939, EBI-21591415;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255}; Lipid-anchor, GPI-
CC       anchor {ECO:0000255}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P0DP60}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P0DP60}. Note=Detected in Purkinje cells soma
CC       and proximal dendrites. {ECO:0000250|UniProtKB:P0DP60}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=LYNX1 {ECO:0000303|Ref.1};
CC         IsoId=P0DP58-1, Q9BZG9-2;
CC         Sequence=Displayed;
CC       Name=2; Synonyms=LYNX1-SLURP2 {ECO:0000303|PubMed:26033490};
CC         IsoId=P0DP58-2, Q9BZG9-1;
CC         Sequence=VSP_058978;
CC   -!- MISCELLANEOUS: Isoform 1 is considered to be an endogenous
CC       'prototoxin', that shares a N-terminal three-finger structure with
CC       snake alpha-neurotoxins. {ECO:0000303|PubMed:21252236}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Based on a naturally occurring readthrough
CC       transcript which produces a LYNX1-SLURP2 fusion protein.
CC       {ECO:0000305|PubMed:26033490}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM005425; AEE61023.1; -; mRNA.
DR   EMBL; AC083841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471162; EAW82299.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82301.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82302.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82303.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82304.1; -; Genomic_DNA.
DR   EMBL; AF321824; AAK01642.1; -; mRNA.
DR   CCDS; CCDS6389.1; -.
DR   RefSeq; NP_076435.1; NM_023946.3. [P0DP58-2]
DR   RefSeq; NP_803252.1; NM_177457.4. [P0DP58-1]
DR   RefSeq; NP_803429.1; NM_177476.3. [P0DP58-1]
DR   RefSeq; NP_803430.1; NM_177477.3. [P0DP58-1]
DR   PDB; 1VYE; Model; -; A=1-80.
DR   PDB; 2L03; NMR; -; A=21-93.
DR   PDBsum; 1VYE; -.
DR   PDBsum; 2L03; -.
DR   SMR; P0DP58; -.
DR   IntAct; P0DP58; 24.
DR   STRING; 9606.ENSP00000479586; -.
DR   iPTMnet; P0DP58; -.
DR   BioMuta; LYNX1; -.
DR   jPOST; P0DP58; -.
DR   MassIVE; P0DP58; -.
DR   PeptideAtlas; P0DP58; -.
DR   PRIDE; P0DP58; -.
DR   Antibodypedia; 21624; 30 antibodies.
DR   Ensembl; ENST00000614491; ENSP00000477648; ENSG00000180155. [P0DP58-1]
DR   Ensembl; ENST00000620006; ENSP00000478402; ENSG00000180155. [P0DP58-1]
DR   Ensembl; ENST00000621401; ENSP00000478390; ENSG00000180155. [P0DP58-1]
DR   Ensembl; ENST00000652477; ENSP00000498325; ENSG00000180155. [P0DP58-1]
DR   GeneID; 111188157; -.
DR   GeneID; 66004; -.
DR   KEGG; hsa:111188157; -.
DR   KEGG; hsa:66004; -.
DR   CTD; 111188157; -.
DR   CTD; 66004; -.
DR   DisGeNET; 111188157; -.
DR   DisGeNET; 66004; -.
DR   GeneCards; LYNX1; -.
DR   HGNC; HGNC:29604; LYNX1.
DR   HPA; ENSG00000180155; Tissue enhanced (brain).
DR   MIM; 606110; gene.
DR   neXtProt; NX_P0DP58; -.
DR   OpenTargets; ENSG00000180155; -.
DR   eggNOG; ENOG502T3MP; Eukaryota.
DR   GeneTree; ENSGT00730000111571; -.
DR   GeneTree; ENSGT00940000153378; -.
DR   OMA; YTPYRMK; -.
DR   OrthoDB; 1544318at2759; -.
DR   PhylomeDB; P0DP58; -.
DR   PathwayCommons; P0DP58; -.
DR   BioGRID-ORCS; 66004; 4 hits in 985 CRISPR screens.
DR   GenomeRNAi; 66004; -.
DR   Pharos; P0DP58; Tbio.
DR   PRO; PR:P0DP58; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P0DP58; protein.
DR   ExpressionAtlas; P0DP58; baseline and differential.
DR   Genevisible; Q9BZG9; HS.
DR   GO; GO:0031225; C:anchored component of membrane; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0033130; F:acetylcholine receptor binding; IDA:UniProtKB.
DR   GO; GO:0030550; F:acetylcholine receptor inhibitor activity; IBA:GO_Central.
DR   GO; GO:0030548; F:acetylcholine receptor regulator activity; IDA:UniProtKB.
DR   GO; GO:0008200; F:ion channel inhibitor activity; IEA:Ensembl.
DR   GO; GO:0099601; P:regulation of neurotransmitter receptor activity; IDA:UniProtKB.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl.
DR   CDD; cd00117; LU; 1.
DR   InterPro; IPR016054; LY6_UPA_recep-like.
DR   InterPro; IPR035076; Toxin/TOLIP.
DR   Pfam; PF00087; Toxin_TOLIP; 1.
DR   SMART; SM00134; LU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Disulfide bond; Endoplasmic reticulum; Glycoprotein; GPI-anchor;
KW   Lipoprotein; Membrane; Reference proteome; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..91
FT                   /note="Ly-6/neurotoxin-like protein 1"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000036154"
FT   PROPEP          92..116
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000440641"
FT   DOMAIN          21..107
FT                   /note="UPAR/Ly6"
FT                   /evidence="ECO:0000255"
FT   LIPID           91
FT                   /note="GPI-anchor amidated cysteine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        23..46
FT                   /evidence="ECO:0000269|PubMed:21252236,
FT                   ECO:0007744|PDB:2L03"
FT   DISULFID        26..33
FT                   /evidence="ECO:0000269|PubMed:21252236,
FT                   ECO:0007744|PDB:2L03"
FT   DISULFID        39..64
FT                   /evidence="ECO:0000269|PubMed:21252236,
FT                   ECO:0007744|PDB:2L03"
FT   DISULFID        68..85
FT                   /evidence="ECO:0000269|PubMed:21252236,
FT                   ECO:0007744|PDB:2L03"
FT   DISULFID        86..91
FT                   /evidence="ECO:0000269|PubMed:21252236,
FT                   ECO:0007744|PDB:2L03"
FT   VAR_SEQ         52..116
FT                   /note="YYTPTRMKVSKSCVPRCFETVYDGYSKHASTTSCCQYDLCNGTGLATPATLA
FT                   LAPILLATLWGLL -> SAAEAIWCHQCTGFGGCSHGSRCLRDSTHCVTTATRVLSNTE
FT                   DLPLVTKMCHIGCPDIPSLGLGPYVSIACCQTSLCNHD (in isoform 2)"
FT                   /id="VSP_058978"
FT   STRAND          22..24
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          26..31
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          36..38
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          45..54
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          57..66
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          75..77
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   STRAND          80..86
FT                   /evidence="ECO:0007744|PDB:2L03"
FT   TURN            89..92
FT                   /evidence="ECO:0007744|PDB:2L03"
SQ   SEQUENCE   116 AA;  12641 MW;  BF5827EB64BFE6F6 CRC64;
     MTPLLTLILV VLMGLPLAQA LDCHVCAYNG DNCFNPMRCP AMVAYCMTTR TYYTPTRMKV
     SKSCVPRCFE TVYDGYSKHA STTSCCQYDL CNGTGLATPA TLALAPILLA TLWGLL
//
